These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 2433514

  • 1. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M, Barhanin J, Borsotto M, Fosset M, Galizzi JP, Renaud JF, Romey G, Schmid A.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
    Borsotto M, Barhanin J, Norman RI, Lazdunski M.
    Biochem Biophys Res Commun; 1984 Aug 16; 122(3):1357-66. PubMed ID: 6089781
    [Abstract] [Full Text] [Related]

  • 4. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC, Ptasienski J, Hosey MM.
    J Pharmacol Exp Ther; 1986 Dec 16; 239(3):768-74. PubMed ID: 2432217
    [Abstract] [Full Text] [Related]

  • 5. [Biochemical and pharmacologic properties of the Ca2+ channel of skeletal muscle: appearance during myogenesis and the relation between its structure and function].
    Renaud JF, Schmid A.
    J Physiol (Paris); 1986 Dec 16; 81(3):177-84. PubMed ID: 2432258
    [Abstract] [Full Text] [Related]

  • 6. Purified calcium channels have three allosterically coupled drug receptors.
    Striessnig J, Goll A, Moosburger K, Glossmann H.
    FEBS Lett; 1986 Mar 03; 197(1-2):204-10. PubMed ID: 2419161
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular approach to the calcium channel.
    Glossmann H, Ferry DR, Goll A, Linn T.
    Adv Myocardiol; 1985 Mar 03; 5():41-76. PubMed ID: 2578683
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
    Renaud JF, Kazazoglou T, Schmid A, Romey G, Lazdunski M.
    Eur J Biochem; 1984 Mar 15; 139(3):673-81. PubMed ID: 6321185
    [Abstract] [Full Text] [Related]

  • 11. The 1,4-dihydropyridine receptor associated with the skeletal muscle voltage-dependent Ca2+ channel. Purification and subunit composition.
    Borsotto M, Barhanin J, Fosset M, Lazdunski M.
    J Biol Chem; 1985 Nov 15; 260(26):14255-63. PubMed ID: 2997201
    [Abstract] [Full Text] [Related]

  • 12. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR, Roeske WR, Yamamura HI.
    Life Sci; 1984 Aug 13; 35(7):721-32. PubMed ID: 6088927
    [Abstract] [Full Text] [Related]

  • 13. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
    Homaidan FR, Donowitz M, Weiland GA, Sharp GW.
    Am J Physiol; 1989 Jul 13; 257(1 Pt 1):G86-93. PubMed ID: 2473655
    [Abstract] [Full Text] [Related]

  • 14. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ, Snowman AM, Snyder SH.
    J Pharmacol Exp Ther; 1986 Jun 13; 237(3):731-8. PubMed ID: 3012067
    [Abstract] [Full Text] [Related]

  • 15. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ, Tuana BS.
    Can J Physiol Pharmacol; 1990 Nov 13; 68(11):1389-95. PubMed ID: 1962734
    [Abstract] [Full Text] [Related]

  • 16. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR, Goll A, Glossmann H.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul 13; 323(3):276-7. PubMed ID: 6312337
    [Abstract] [Full Text] [Related]

  • 17. Solubilization of calcium channel antagonist binding sites from rat brain.
    Finkel MS, Tallman JF.
    J Neurochem; 1987 Sep 13; 49(3):921-7. PubMed ID: 2440991
    [Abstract] [Full Text] [Related]

  • 18. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    Murphy BJ, Rogers CA, Sunahara RK, Lemaire S, Tuana BS.
    Mol Pharmacol; 1990 Feb 13; 37(2):173-81. PubMed ID: 2154669
    [Abstract] [Full Text] [Related]

  • 19. Calcium channels: basic properties as revealed by radioligand binding studies.
    Glossmann H, Ferry DR, Goll A, Striessnig J, Schober M.
    J Cardiovasc Pharmacol; 1985 Feb 13; 7 Suppl 6():S20-30. PubMed ID: 2414589
    [Abstract] [Full Text] [Related]

  • 20. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC, Stafford GA, Henstenberg JD, Sharp GW, Weiland GA.
    J Pharmacol Exp Ther; 1991 Aug 13; 258(2):652-62. PubMed ID: 1713965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.